HRP20211762T1 - Derivati benzoksaborola za liječenje bakterijskih infekcija - Google Patents
Derivati benzoksaborola za liječenje bakterijskih infekcija Download PDFInfo
- Publication number
- HRP20211762T1 HRP20211762T1 HRP20211762TT HRP20211762T HRP20211762T1 HR P20211762 T1 HRP20211762 T1 HR P20211762T1 HR P20211762T T HRP20211762T T HR P20211762TT HR P20211762 T HRP20211762 T HR P20211762T HR P20211762 T1 HRP20211762 T1 HR P20211762T1
- Authority
- HR
- Croatia
- Prior art keywords
- solvate
- hydrate
- salt
- compound according
- pharmaceutically acceptable
- Prior art date
Links
- GDMJXXLVTYSBBE-UHFFFAOYSA-N 1,2-benzoxaborole Chemical class C1=CC=C2OB=CC2=C1 GDMJXXLVTYSBBE-UHFFFAOYSA-N 0.000 title 1
- 208000035143 Bacterial infection Diseases 0.000 title 1
- 208000022362 bacterial infectious disease Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 15
- 150000003839 salts Chemical class 0.000 claims 15
- 239000012453 solvate Substances 0.000 claims 13
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- 239000000460 chlorine Chemical group 0.000 claims 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 2
- -1 methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy Chemical group 0.000 claims 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 206010062207 Mycobacterial infection Diseases 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 150000001721 carbon Chemical group 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 229910052740 iodine Chemical group 0.000 claims 1
- 239000011630 iodine Chemical group 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 208000027531 mycobacterial infectious disease Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000005920 sec-butoxy group Chemical group 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 201000008827 tuberculosis Diseases 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Claims (15)
1. Spoj koji ima strukturu koja je:
[image]
u kojoj
R4 je izabran iz grupe koja se sastoji od sljedećih: halogen, metil, etil, propil, izopropil, butil, izobutil, sek-butil, metoksi, etoksi, propoksi, izopropoksi, butoksi, izobutoksi i sek-butoksi; i
gdje a je 2, 3 ili 4; i
R12 je izabran iz grupe koja se sastoji od sljedećih: H, OH, NH2, metil, etil, - NHS(O)2CH3, cijano, -NHC(O)CH3, -NHC(O)NHCH2CH3, -C(O)NH2, -C(O)OH, 4-(metoksi)fenil, benzil, benzoksi, -NHC(O)OCH2Ph, -C(O)NHCH2CH2OH i -C(NH2)(NH);
ili njegova sol, hidrat ili solvat.
2. Spoj prema zahtjevu 1 ili njegova sol, hidrat ili solvat, koji ima strukturu koja je:
[image]
u kojoj C* je stereocentar atoma ugljika koji ima konfiguraciju koja je (R) ili (S).;
3. Spoj prema zahtjevu 2 ili njegova sol, hidrat ili solvat, naznačeno time što C* stereocentar je u (S) konfiguraciji.
4. Spoj prema zahtjevu 1 ili njegova sol, hidrat ili solvat, naznačeno time što R4 je izabran iz grupe koja se sastoji od fluora, klora, broma i joda.
5. Spoj prema zahtjevu 4 ili njegova sol, hidrat ili solvat, naznačeno time što R4 je klor.
6. Spoj prema zahtjevu 1 do 3 ili njegova sol, hidrat ili solvat, naznačeno time što R4 je izabran iz grupe koja se sastoji od sljedećih: metil, etil, propil, izopropil, butil, izobutil, sek-butil.
7. Spoj prema zahtjevu 6 ili njegova sol, hidrat ili solvat, naznačeno time što R4 je metil.
8. Spoj prema bilo kojem od zahtjeva 1 do 6 ili njegova sol, hidrat ili solvat, naznačeno time što a je 2.
9. Spoj prema bilo kojem od zahtjeva 1 do 6 ili njegova sol, hidrat ili solvat, naznačeno time što R12 je OH.
10. Kompozicija koja sadrži:
a) prvi stereoizomer spoja prema bilo kojem od zahtjeva 2 do 9 ili njegovu sol, hidrat ili solvat;
b) najmanje jedan dodatni stereoizomer prvog stereoizomera;
pri čemu je prvi stereoizomer prisutan u enantiomernom višku od najmanje 80% u odnosu na navedeni najmanje jedan dodatni stereoizomer.
11. Kombinacija koja sadrži spoj prema bilo kojem od zahtjeva 1 do 9 ili njegovu farmaceutski prihvatljivu sol, zajedno sa najmanje jednim drugim terapeutski aktivnim sredstvom.
12. Farmaceutska formulacija koja sadrži:
a) spoj prema bilo kojem od zahtjeva 1 do 9 ili njegovu farmaceutski prihvatljivu sol; i
b) farmaceutski prihvatljiv ekscipijent.
13. Spoj ili njegova farmaceutski prihvatljiva sol, hidrat ili solvat, kako je definirano u bilo kojem od zahtjeva 1 do 9, za uporabu u terapiji.
14. Spoj ili njegova farmaceutski prihvatljiva sol, hidrat ili solvat, kako je definirano u bilo kojem od zahtjeva 1 do 9, za uporabu u liječenju bolesti izazvane infekcijom mikobakterijom.
15. Spoj ili njegova farmaceutski prihvatljiva sol, hidrat ili solvat, kako je definirano u bilo kojem od zahtjeva 1 do 9, za uporabu u liječenju tuberkuloze.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38059610P | 2010-09-07 | 2010-09-07 | |
EP17176654.6A EP3251678B1 (en) | 2010-09-07 | 2011-09-07 | Benzoxaborole derivatives for treating bacterial infections |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20211762T1 true HRP20211762T1 (hr) | 2022-02-18 |
Family
ID=44653589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20211762TT HRP20211762T1 (hr) | 2010-09-07 | 2011-09-07 | Derivati benzoksaborola za liječenje bakterijskih infekcija |
Country Status (25)
Country | Link |
---|---|
US (4) | US8703742B2 (hr) |
EP (2) | EP3251678B1 (hr) |
JP (4) | JP5952280B2 (hr) |
KR (2) | KR102152901B1 (hr) |
CN (2) | CN108610356B (hr) |
AU (1) | AU2011299243C1 (hr) |
BR (1) | BR112013005426B1 (hr) |
CA (1) | CA2810021C (hr) |
CY (1) | CY1124728T1 (hr) |
DK (2) | DK3251678T3 (hr) |
EA (2) | EA033311B1 (hr) |
ES (2) | ES2635333T3 (hr) |
HK (1) | HK1247841A1 (hr) |
HR (1) | HRP20211762T1 (hr) |
HU (1) | HUE059033T2 (hr) |
IL (2) | IL225000A (hr) |
LT (1) | LT3251678T (hr) |
MX (1) | MX338209B (hr) |
PL (1) | PL3251678T3 (hr) |
PT (1) | PT3251678T (hr) |
RS (1) | RS62548B1 (hr) |
SG (2) | SG187969A1 (hr) |
SI (1) | SI3251678T1 (hr) |
WO (1) | WO2012033858A2 (hr) |
ZA (1) | ZA201301598B (hr) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2008131324A (ru) | 2005-12-30 | 2010-02-10 | Анакор Фармасьютикалз, Инк. (Us) | Борсодержащие малые молекулы |
US9440994B2 (en) * | 2009-08-14 | 2016-09-13 | Anacor Pharmaceuticals, Inc. | Boron containing small molecules as antiprotozoal agents |
US8716478B2 (en) | 2010-01-27 | 2014-05-06 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
CN108610356B (zh) * | 2010-09-07 | 2021-02-26 | 阿纳科制药公司 | 苯并氧杂硼杂环戊二烯衍生物用于治疗细菌感染 |
JP6031122B2 (ja) * | 2011-12-22 | 2016-11-24 | ミクウルク ファーマシューティカルズ,インコーポレイテッド | 抗微生物療法のための三環式ホウ素化合物 |
US9585396B2 (en) | 2013-01-30 | 2017-03-07 | Agrofresh Inc. | Volatile applications against pathogens |
US10070649B2 (en) | 2013-01-30 | 2018-09-11 | Agrofresh Inc. | Volatile applications against pathogens |
US11039617B2 (en) | 2013-01-30 | 2021-06-22 | Agrofresh Inc. | Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness |
CN105101791B (zh) | 2013-01-30 | 2017-11-17 | 美国陶氏益农公司 | 苯硼酸半酯作为挥发性抗微生物剂在肉类、植物或植物部分上的用途 |
US8669207B1 (en) | 2013-01-30 | 2014-03-11 | Dow Agrosciences, Llc. | Compounds and compositions |
AP2015008638A0 (en) | 2013-02-01 | 2015-08-31 | Anacor Pharmaceuticals Inc | Boron-containing small molecules as antiprotozoal agents |
KR101636431B1 (ko) | 2013-07-30 | 2016-07-05 | 동아에스티 주식회사 | 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도 |
HRP20220384T1 (hr) * | 2013-08-09 | 2022-07-22 | Glaxosmithkline Intellectual Property (No. 2) Limited | Triciklički benzoksaborol spojevi i njihove uporabe |
EA038093B1 (ru) * | 2013-12-20 | 2021-07-05 | Глаксосмитклайн Интеллекчуал Проперти (№2) Лимитед | Способ лечения заболевания, вызванного инфекцией комплекса mycobacterium tuberculosis, с использованием (s)-(3-хлор-7,8-дигидро-2h-1,6,9-триокса-9a-борабензо[cd]азулен-2-ил)метанамина или его фармацевтически приемлемой соли |
CA2953881A1 (en) | 2014-07-01 | 2016-01-07 | Daiichi Sankyo Company, Limited | Tricyclic benzoxaboroles as antibacterial agents |
MA41494B1 (fr) | 2015-02-12 | 2020-10-28 | Glaxosmithkline Ip No 2 Ltd | Composés benzoxaborole substitués en position 4 et utilisations associées |
NZ745681A (en) | 2016-03-07 | 2022-05-27 | Agrofresh Inc | Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops |
EP3609504A4 (en) | 2017-03-01 | 2021-03-03 | Anacor Pharmaceuticals, Inc. | NEW OXABOROLE ANALOGUES AND USES OF THE LATEST |
CN111655035A (zh) | 2017-11-30 | 2020-09-11 | 博瑞金股份有限公司 | 苯并氧杂硼杂环戊烯化合物和其制剂 |
CN108727176B (zh) * | 2018-07-26 | 2021-05-18 | 荆楚理工学院 | 一种制备5-卤-2,3-二羟基苯甲醛的方法 |
WO2020041200A1 (en) | 2018-08-18 | 2020-02-27 | Boragen Inc. | Solid forms of substituted benzoxaborole and compositions thereof |
US20220275007A1 (en) * | 2019-07-30 | 2022-09-01 | Boragen, Inc. | Flow reaction process for manufacture of boron-containing agrochemicals |
CN110664756B (zh) * | 2019-10-09 | 2020-11-17 | 吉林大学 | 一种小儿外伤喷雾剂及其制备方法 |
WO2022043936A1 (en) | 2020-08-31 | 2022-03-03 | Pfizer Inc. | Methods of protecting rna |
EP4384527A1 (en) * | 2022-06-23 | 2024-06-19 | Micurx Pharmaceuticals, Inc. | Prodrugs of boron compounds and their use in treating bacterial infections |
CA3239096A1 (en) * | 2022-06-23 | 2023-12-28 | Shanghai Micurx Pharmaceutical Co., Ltd. | Methods and uses of boron compounds in the treatment of nontuberculous mycobacterium infections and pharmaceutical compositions for treatment of same |
CN115572218B (zh) * | 2022-08-29 | 2024-04-16 | 江阴勒森生物科技有限公司 | 一种2-溴-3-羟基苯甲醛及其相关化学发光底物中间体的制备方法 |
Family Cites Families (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2260336A (en) | 1939-10-16 | 1941-10-28 | Dow Chemical Co | Method of preparation of organic borates |
US3686398A (en) | 1970-07-20 | 1972-08-22 | Chevron Res | 10,9-boroxarophenanthrene as fungicides |
GB1396904A (en) | 1972-08-11 | 1975-06-11 | Ici Ltd | Method for the control of micro-organisms |
US4766113A (en) | 1975-10-24 | 1988-08-23 | Chapman Chemical Company | Antimicrobial compositions and methods of using same |
US4602011A (en) | 1975-10-24 | 1986-07-22 | Chapman Chemical Company | Antimicrobial compositions and methods of using same |
US4716035A (en) | 1985-05-24 | 1987-12-29 | The Procter & Gamble Company | Oral compositions and methods for treating gingivitis |
US5962498A (en) | 1986-06-11 | 1999-10-05 | Procyon Pharmaceuticals, Inc. | Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity |
US4894220A (en) | 1987-01-30 | 1990-01-16 | Colgate-Palmolive Company | Antibacterial antiplaque oral composition |
US4919934A (en) | 1989-03-02 | 1990-04-24 | Richardson-Vicks Inc. | Cosmetic sticks |
US5274792A (en) | 1989-08-19 | 1993-12-28 | Fujitsu Limited | Information processing apparatus with parallel instruction decoding |
SG47101A1 (en) | 1992-07-31 | 1998-03-20 | Us Bioscience | Crystalline amifostine compositions and methods for the preparation and use of same |
US5348947A (en) | 1993-05-07 | 1994-09-20 | American Cyanamid Company | Diarylboron ester and thioester fungicidal agents |
US5348948A (en) | 1993-05-07 | 1994-09-20 | American Cyanamid Company | 2,2-diaryl-1-(oxa and thia)-2a-azonia-2-borataacenaphthene fungicidal |
US5594151A (en) | 1994-01-28 | 1997-01-14 | Prolinx, Inc. | Phenylboronic acid complexing reagents derived from aminosalicylic acid |
GB9411587D0 (en) | 1994-06-09 | 1994-08-03 | Zeneca Ltd | Compound, composition and use |
US6083903A (en) | 1994-10-28 | 2000-07-04 | Leukosite, Inc. | Boronic ester and acid compounds, synthesis and uses |
GB9500856D0 (en) | 1995-01-17 | 1995-03-08 | Zeneca Ltd | Composition and use |
GB9604926D0 (en) | 1996-03-08 | 1996-05-08 | Sandoz Ltd | Organic compounds |
JP4373497B2 (ja) | 1996-06-19 | 2009-11-25 | ローン−プーラン・ロレ・リミテツド | 置換されたアザビシクロ化合物、ならびにtnfおよびサイクリックampホスホジエステラーゼ産生の阻害剤としてのそれらの使用 |
US5831046A (en) | 1996-08-05 | 1998-11-03 | Prolinx, Incorporated | Boronic acid-contaning nucleic acid monomers |
AU4486097A (en) | 1996-09-19 | 1998-04-14 | Board Of Trustees Of The Leland Stanford Junior University | Dna adenine methyltransferases and uses thereof |
DE69730737D1 (de) | 1996-12-02 | 2004-10-21 | Chisso Corp | Optisch aktive nitroalkohol-derivate, optisch aktive aminoalkohol-derivate und verfahren zu ihrer herstellung |
US6221640B1 (en) | 1997-05-14 | 2001-04-24 | Cubist Pharmaceuticals, Inc. | Enterococcal aminoacyl-trna synthetase proteins, nucleic acids and strains comprising same |
DE19829947A1 (de) | 1998-07-04 | 2000-01-05 | Bayer Ag | Elektrolumineszierende Anordnungen mit Bor-Chelaten |
US6462036B1 (en) | 1998-11-06 | 2002-10-08 | Basf Aktiengesellschaft | Tricyclic pyrazole derivatives |
KR20010086005A (ko) | 1998-11-06 | 2001-09-07 | 스타르크, 카르크 | 트리사이클릭 피라졸 유도체 |
WO2000044387A1 (fr) | 1999-01-29 | 2000-08-03 | Nitto Kasei Co., Ltd. | Composes organobores presentant une activite de coccidiostats |
JP2003501431A (ja) | 1999-05-25 | 2003-01-14 | ザ ペン ステート リサーチ ファウンデイション | Dnaメチル基転移酵素阻害剤 |
WO2001014578A1 (en) | 1999-08-25 | 2001-03-01 | Ambergen, Inc. | Methods for the detection, analysis and isolation of nascent proteins |
US6306628B1 (en) | 1999-08-25 | 2001-10-23 | Ambergen, Incorporated | Methods for the detection, analysis and isolation of Nascent proteins |
AU7995300A (en) | 1999-10-05 | 2001-05-10 | Bethesda Pharmaceuticals, Inc. | Dithiolane derivatives |
WO2001049302A1 (en) | 2000-01-06 | 2001-07-12 | Marantech Holding, Llc | Compositions and methods for facilitating skin growth and managing skin conditions |
US6521619B2 (en) | 2000-06-29 | 2003-02-18 | Icos Corporation | Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents |
AU2001275930B2 (en) | 2000-07-14 | 2007-05-10 | Eisai Inc. | Alpha-msh related compounds and methods of use |
DE60124759T2 (de) | 2000-11-30 | 2007-03-15 | The Penn State Research Foundation | Dna methyl transferase inhibitoren |
DE10110051C2 (de) | 2001-03-02 | 2003-07-03 | Clariant Gmbh | Verfahren zur Herstellung von Boron- und Borinsäuren |
US6737042B2 (en) | 2001-05-24 | 2004-05-18 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
US20030051728A1 (en) | 2001-06-05 | 2003-03-20 | Lloyd Peter M. | Method and device for delivering a physiologically active compound |
GB0117645D0 (en) | 2001-07-19 | 2001-09-12 | Isis Innovation | Therapeutic stratergies for prevention and treatment of alzheimers disease |
DE10143979A1 (de) | 2001-09-07 | 2003-03-27 | Clariant Gmbh | Verfahren zur Herstellung von Bisallylboranen und nicht-aromatischen Boronsäuren |
EP1444981A1 (en) | 2001-10-11 | 2004-08-11 | Katsuhiko Mikoshiba | Intracellular calcium concentration increase inhibitors |
CN1325504C (zh) | 2002-01-10 | 2007-07-11 | 宾夕法尼亚州研究基金会 | 制备二芳基硼酸烷基酯和络合的二芳基硼酸的方法 |
EP1578362A4 (en) | 2002-07-09 | 2008-11-05 | Point Therapeutics Inc | COMBINATION THERAPY WITH A BOROPROLINE COMPOUND |
CN100384791C (zh) | 2002-12-02 | 2008-04-30 | 索尔维亚斯股份公司 | 碳-杂原子双键的催化氢化 |
WO2004056322A2 (en) | 2002-12-18 | 2004-07-08 | Anacor Pharmaceuticals, Inc. | Antibiotics containing borinic acid complexes and methods of use |
US7390806B2 (en) | 2002-12-18 | 2008-06-24 | Anacor Pharmaceuticals, Inc. | Antibiotics containing borinic acid complexes and methods of use |
WO2005000200A2 (en) | 2003-05-09 | 2005-01-06 | Sugen, Inc. | Novel kinases |
US7465836B2 (en) | 2003-06-16 | 2008-12-16 | Anacor Pharmaceuticals, Inc. | Hydrolytically-resistant boron-containing therapeutics and methods of use |
ES2464444T3 (es) | 2004-05-12 | 2014-06-02 | The Brigham And Women's Hospital, Inc. | Gelsolina para uso en el tratamiento de infecciones |
AR049915A1 (es) | 2004-06-14 | 2006-09-13 | Anacor Pharmaceuticals Inc | Compuestos con contenido de boro y metodos de uso de los mismos |
US20060111388A1 (en) | 2004-11-19 | 2006-05-25 | University Of North Texas Health Science Center At Fort Worth | Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye |
GB0501944D0 (en) | 2005-01-31 | 2005-03-09 | Univ Cambridge Tech | Compounds for use in chemical detection and/or quantitation |
EP1853251B1 (en) | 2005-02-16 | 2013-04-24 | Anacor Pharmaceuticals, Inc. | Halogen-substituted boronophthalides for the treatment of infections |
EP1856113B1 (en) | 2005-03-08 | 2016-01-06 | Agency for Science, Technology and Research | Chiral bisoxazoline catalysts |
US20060222671A1 (en) | 2005-03-30 | 2006-10-05 | Astion Development A/S | Dermatological compositions and salts for the treatment of dermatological diseases |
WO2007022437A2 (en) | 2005-08-18 | 2007-02-22 | Auspex Pharmaceuticals, Inc. | Therapeutic agents for the treatment of cancer and metabolic disorders |
RU2008131324A (ru) | 2005-12-30 | 2010-02-10 | Анакор Фармасьютикалз, Инк. (Us) | Борсодержащие малые молекулы |
HUE044941T2 (hu) * | 2006-02-16 | 2019-11-28 | Anacor Pharmaceuticals Inc | Bórtartalmú kismolekulák mint gyulladásgátló szerek |
EP2015757A4 (en) * | 2006-05-02 | 2011-01-26 | Anacor Pharmaceuticals Inc | HYDROLYSERESISTENT, BOROYED THERAPEUTIC USES |
US20070286822A1 (en) | 2006-06-12 | 2007-12-13 | Anacor Pharmaceuticals Inc. | Compounds for the Treatment of Periodontal Disease |
EP2044091A4 (en) | 2006-06-12 | 2010-08-04 | Anacor Pharmaceuticals Inc | COMPOUNDS FOR TREATING A PERIODONTAL DISEASE |
KR100848491B1 (ko) | 2007-01-16 | 2008-07-28 | 영진약품공업주식회사 | 베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법 |
JO3396B1 (ar) * | 2007-06-20 | 2019-10-20 | Anacor Pharmaceuticals Inc | جزيئات صغيرة تحتوي على البورون |
KR20150065941A (ko) | 2008-03-06 | 2015-06-15 | 아나코르 파마슈티칼스 인코포레이티드 | 소염제로써 붕소가 함유된 소분자 |
EP2187893A4 (en) | 2008-03-06 | 2012-02-22 | Anacor Pharmaceuticals Inc | SMALL BORON-CONTAINING MOLECULES AS ANTI-INFLAMMATORY AGENTS |
EP2285384A4 (en) | 2008-05-12 | 2012-04-25 | Anacor Pharmaceuticals Inc | BORN SMALL MOLECULES |
US8461336B2 (en) | 2008-09-04 | 2013-06-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
WO2010045505A1 (en) | 2008-10-15 | 2010-04-22 | Anacor Pharmaceuticals, Inc | Boron-containing small molecules as anti-protozoal agents |
WO2010045503A1 (en) | 2008-10-15 | 2010-04-22 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-protozoal agents |
SG172040A1 (en) | 2008-12-17 | 2011-07-28 | Anacor Pharmaceuticals Inc | Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2] oxaborol-1-ol |
EP2458995A1 (en) | 2009-07-28 | 2012-06-06 | Anacor Pharmaceuticals, Inc. | Trisubstituted boron-containing molecules |
CN108610356B (zh) * | 2010-09-07 | 2021-02-26 | 阿纳科制药公司 | 苯并氧杂硼杂环戊二烯衍生物用于治疗细菌感染 |
-
2011
- 2011-09-07 CN CN201810051113.2A patent/CN108610356B/zh active Active
- 2011-09-07 AU AU2011299243A patent/AU2011299243C1/en active Active
- 2011-09-07 MX MX2013002651A patent/MX338209B/es active IP Right Grant
- 2011-09-07 ES ES11758050.6T patent/ES2635333T3/es active Active
- 2011-09-07 CN CN2011800427618A patent/CN103140228A/zh active Pending
- 2011-09-07 CA CA2810021A patent/CA2810021C/en active Active
- 2011-09-07 EA EA201791850A patent/EA033311B1/ru unknown
- 2011-09-07 KR KR1020197003860A patent/KR102152901B1/ko active IP Right Grant
- 2011-09-07 JP JP2013527375A patent/JP5952280B2/ja active Active
- 2011-09-07 SG SG2013014493A patent/SG187969A1/en unknown
- 2011-09-07 EP EP17176654.6A patent/EP3251678B1/en active Active
- 2011-09-07 KR KR1020137005717A patent/KR101949423B1/ko active IP Right Grant
- 2011-09-07 US US13/227,444 patent/US8703742B2/en active Active
- 2011-09-07 WO PCT/US2011/050728 patent/WO2012033858A2/en active Application Filing
- 2011-09-07 EA EA201390274A patent/EA028743B1/ru not_active IP Right Cessation
- 2011-09-07 LT LTEP17176654.6T patent/LT3251678T/lt unknown
- 2011-09-07 RS RS20211391A patent/RS62548B1/sr unknown
- 2011-09-07 DK DK17176654.6T patent/DK3251678T3/da active
- 2011-09-07 BR BR112013005426-3A patent/BR112013005426B1/pt active IP Right Grant
- 2011-09-07 HR HRP20211762TT patent/HRP20211762T1/hr unknown
- 2011-09-07 SI SI201132017T patent/SI3251678T1/sl unknown
- 2011-09-07 PL PL17176654T patent/PL3251678T3/pl unknown
- 2011-09-07 SG SG10201507032YA patent/SG10201507032YA/en unknown
- 2011-09-07 HU HUE17176654A patent/HUE059033T2/hu unknown
- 2011-09-07 DK DK11758050.6T patent/DK2613788T3/en active
- 2011-09-07 PT PT171766546T patent/PT3251678T/pt unknown
- 2011-09-07 ES ES17176654T patent/ES2898695T3/es active Active
- 2011-09-07 EP EP11758050.6A patent/EP2613788B1/en active Active
-
2013
- 2013-02-28 IL IL225000A patent/IL225000A/en active IP Right Grant
- 2013-03-01 ZA ZA2013/01598A patent/ZA201301598B/en unknown
-
2014
- 2014-03-21 US US14/221,637 patent/US9751898B2/en active Active
-
2016
- 2016-03-13 IL IL244556A patent/IL244556B/en active IP Right Grant
- 2016-06-09 JP JP2016114971A patent/JP2016199558A/ja not_active Withdrawn
-
2017
- 2017-08-24 US US15/685,846 patent/US20170355719A1/en not_active Abandoned
- 2017-10-06 JP JP2017195759A patent/JP6491294B2/ja active Active
-
2018
- 2018-06-06 HK HK18107388.5A patent/HK1247841A1/zh unknown
-
2019
- 2019-02-28 JP JP2019035145A patent/JP2019112431A/ja active Pending
- 2019-07-30 US US16/526,248 patent/US11008345B2/en active Active
-
2021
- 2021-11-16 CY CY20211100990T patent/CY1124728T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20211762T1 (hr) | Derivati benzoksaborola za liječenje bakterijskih infekcija | |
HRP20211224T1 (hr) | Derivati pirimidina za liječenje virusnih infekcija | |
HRP20151000T1 (hr) | Antivirusni spojevi | |
HRP20171512T1 (hr) | Derivati betulina | |
RS54258B1 (en) | SRC / ABL INHIBITOR FORMULATIONS | |
JP2013541514A5 (hr) | ||
JP2013528600A5 (hr) | ||
HRP20210942T1 (hr) | Supstituirani derivati indolina kao inhibitori replikacije denga virusa | |
HRP20090077A2 (hr) | Modulatori farmakokinetičkih svojstava terapeutika | |
HRP20140011T1 (hr) | Derivati oksazina i njihova uporaba u lijeäśenju neuroloških poremeä†aja | |
WO2006069155A3 (en) | Inhibitors of protein arginine methyl transferases | |
EA201001455A1 (ru) | Пиридины и пиразины в качестве ингибиторов pi3k (фосфатидилинозиткиназы-3) | |
FR2903107B1 (fr) | Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique | |
EA200970535A1 (ru) | Антибактериальные производные хинолина | |
JP2011527299A5 (hr) | ||
JP2011507896A5 (hr) | ||
UA109421C2 (uk) | Фармацевтична композиція, яка містить ліганди сигма-рецептора | |
EA200970534A1 (ru) | Антибактериальные производные хинолина | |
MX2009010165A (es) | Nuevas imidazo[4,5-b]piridina-7-carboxamidas 704. | |
MX2012006297A (es) | Uso topico hidroxitirosol y derivados para la prevencion de la infeccion por vih. | |
WO2008143649A3 (en) | Novel oxazolidinone compounds as antiinfective agents | |
RU2011111117A (ru) | Лечение аутоиммунных заболеваний | |
EA201070018A1 (ru) | Замещенные 2-[2-(фенил)этиламино] алканамидные производные и применение указанных соединений в качестве модуляторов натриевых и/или кальциевых каналов | |
JP2012508256A5 (hr) | ||
EA201270602A1 (ru) | N-((1r,2s,5r)-5-(трет-бутиламино)-2-((s)-3-(7-трет-бутилпиразоло[1,5-а][1,3,5]триазин-4-иламино)-2-оксопирролидин-1-ил)циклогексил)ацетамид в качестве двойного модулятора активности хемокиновых рецепторов, его кристаллические формы и способы получения |